Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Squire

Showing results (271-280 of 291) with videos related to

Pageof 30
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 7, 2014
Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimensE Gospodarevskaya, O Tulloch, C Bunga, et al.
QJM : Monthly Journal of the Association of Physicians|May 17, 2015
Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysisC Berry, K K Poppe, G D Gamble, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 17, 2019
Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetesGaurav S Gulsin, Prathap Kanagala, Daniel C S Chan, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2023
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studiesJoanna Osmanska, Katriona Brooksbank, Kieran F Docherty, et al.
Heart (British Cardiac Society)|August 10, 2022
Rationale and design of a randomised trial of intravenous iron in patients with heart failurePaul R Kalra, John Gf Cleland, Mark C Petrie, et al.
European Journal of Heart Failure|March 24, 2021
Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study)Pankaj Gupta, Adriaan A Voors, Prashanth Patel, et al.
BMC Infectious Diseases|August 17, 2017
Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in BrazilD M P Ramalho, P F C Miranda, M K Andrade, et al.
European Heart Journal|January 25, 2015
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisColette E Jackson, Davide Castagno, Aldo P Maggioni, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 16, 2019
Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network studyPrathap Kanagala, Iain B Squire, Donald J L Jones, et al.
Circulation|May 13, 2021
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial InfarctionKieran F Docherty, Ross T Campbell, Katriona J M Brooksbank, et al.
Pageof 30

Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 7, 2014
Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimensE Gospodarevskaya, O Tulloch, C Bunga, et al.
QJM : Monthly Journal of the Association of Physicians|May 17, 2015
Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysisC Berry, K K Poppe, G D Gamble, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 17, 2019
Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetesGaurav S Gulsin, Prathap Kanagala, Daniel C S Chan, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2023
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studiesJoanna Osmanska, Katriona Brooksbank, Kieran F Docherty, et al.
Heart (British Cardiac Society)|August 10, 2022
Rationale and design of a randomised trial of intravenous iron in patients with heart failurePaul R Kalra, John Gf Cleland, Mark C Petrie, et al.
European Journal of Heart Failure|March 24, 2021
Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study)Pankaj Gupta, Adriaan A Voors, Prashanth Patel, et al.
BMC Infectious Diseases|August 17, 2017
Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in BrazilD M P Ramalho, P F C Miranda, M K Andrade, et al.
European Heart Journal|January 25, 2015
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisColette E Jackson, Davide Castagno, Aldo P Maggioni, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 16, 2019
Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network studyPrathap Kanagala, Iain B Squire, Donald J L Jones, et al.
Circulation|May 13, 2021
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial InfarctionKieran F Docherty, Ross T Campbell, Katriona J M Brooksbank, et al.
Pageof 30